Column Group LLC Tenaya Therapeutics, Inc. Transaction History
Column Group LLC
- $69.5 Million
- Q3 2024
A detailed history of Column Group LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Column Group LLC holds 9,400,290 shares of TNYA stock, worth $14.1 Million. This represents 26.09% of its overall portfolio holdings.
Number of Shares
9,400,290
Previous 9,400,290
-0.0%
Holding current value
$14.1 Million
Previous $29.1 Million
37.74%
% of portfolio
26.09%
Previous 40.92%
Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Ra Capital Management, L.P. Boston, MA6.98MShares$10.5 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$10.1 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$6.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$4.82 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$4.54 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $62M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...